TEAD1 and neoplasm: Histological analysis at 3.5 months after transplantation, a relatively early time point in PDX formation, confirmed tumor engraftment in both sham and TEAD1KO cells (Fig. 4a) as well as the stable loss of TEAD1 protein in TEAD1KO cells (Fig. 4b).